Advanced
  Home Compare Reports

Comparison with Similar Reports

Orthopedic Braces & Supports Market by Product (Knee, Ankle, Hip, Spine, Shoulder, Neck, Elbow, Hand, Wrist), Category (Soft, Rigid, Hinged), Applicat...

Publisher:        MarketsandMarkets

# of Pages:        336

Rating: 

1 User License $4,950

Publication Date:  March, 2022

Price:       $4,950 / User License




1 INTRODUCTION 29
1.1 OBJECTIVES OF THE STUDY 29
1.2 MARKET DEFINITION 29
1.2.1 INCLUSIONS & EXCLUSIONS OF THE STUDY 30
1.3 MARKET SCOPE 31
1.3.1 MARKETS COVERED 31
1.4 YEARS CONSIDERED FOR THE STUDY 32
1.5 CURRENCY USED FOR THE STUDY 32
1.6 MAJOR MARKET STAKEHOLDERS 32
1.7 SUMMARY OF CHANGES 33
2 RESEARCH METHODOLOGY 34
2.1 RESEARCH DATA 34
FIGURE 1 RESEARCH DESIGN 34
2.1.1 SECONDARY DATA 35
2.1.1.1 Secondary data sources 36
2.1.2 PRIMARY DATA 37
FIGURE 2 BREAKDOWN OF PRIMARIES: ORTHOPEDIC BRACES
AND SUPPORTS MARKET 37
2.2 MARKET ESTIMATION METHODOLOGY 37
FIGURE 3 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING 38
2.2.1 END-USER-BASED MARKET ESTIMATION 38
FIGURE 4 MARKET SIZE ESTIMATION: END-USER-BASED APPROACH 39
2.2.2 REVENUE MAPPING-BASED MARKET ESTIMATION 39
FIGURE 5 MARKET SIZE ESTIMATION: REVENUE MAPPING-BASED APPROACH 40
2.2.3 PRIMARY RESEARCH VALIDATION 40
2.3 COVID-19 ECONOMIC ASSESSMENT 41
2.4 MARKET ESTIMATION AND DATA TRIANGULATION 42
FIGURE 6 DATA TRIANGULATION METHODOLOGY 42
2.5 RESEARCH ASSUMPTIONS 43
2.6 RESEARCH LIMITATIONS 43
3 EXECUTIVE SUMMARY 44
FIGURE 7 ORTHOPEDIC BRACES AND SUPPORTS MARKET, BY PRODUCT,
2022 VS. 2027 (USD MILLION) 44
FIGURE 8 ORTHOPEDIC BRACES AND SUPPORTS MARKET, BY TYPE, 2022 VS. 2027 45
FIGURE 9 ORTHOPEDIC BRACES AND SUPPORTS MARKET, BY APPLICATION,
2022 VS. 2027 (USD MILLION) 46
FIGURE 10 ORTHOPEDIC BRACES AND SUPPORTS MARKET, BY DISTRIBUTION CHANNEL, 2022 VS. 2027 (USD MILLION) 47
FIGURE 11 GEOGRAPHIC SNAPSHOT: ORTHOPEDIC BRACES AND SUPPORTS MARKET 48
4 PREMIUM INSIGHTS 49
4.1 ORTHOPEDIC BRACES AND SUPPORTS MARKET OVERVIEW 49
FIGURE 12 INCREASING PREVALENCE OF ORTHOPEDIC DISEASES & DISORDERS TO DRIVE THE DEMAND FOR ORTHOPEDIC BRACES AND SUPPORTS TILL 2027 49
4.2 ORTHOPEDIC BRACES AND SUPPORTS MARKET, BY PRODUCT 50
FIGURE 13 KNEE BRACES AND SUPPORTS TO DOMINATE THE OVERALL ORTHOPEDIC BRACES AND SUPPORTS MARKET DURING THE FORECAST PERIOD 50
4.3 ORTHOPEDIC BRACES AND SUPPORTS MARKET, BY TYPE 51
FIGURE 14 SOFT & ELASTIC BRACES AND SUPPORTS TO REGISTER THE HIGHEST GROWTH RATE DURING THE FORECAST PERIOD 51
4.4 ORTHOPEDIC BRACES AND SUPPORTS MARKET, BY APPLICATION 52
FIGURE 15 LIGAMENT INJURY APPLICATIONS TO DOMINATE THE ORTHOPEDIC BRACES AND SUPPORTS MARKET DURING THE FORECAST PERIOD 52
4.5 ASIA PACIFIC: ORTHOPEDIC BRACES AND SUPPORTS MARKET, BY DISTRIBUTION CHANNEL AND COUNTRY (2022) 53
FIGURE 16 HOSPITALS & SURGICAL CENTERS TO DOMINATE THE APAC ORTHOPEDIC BRACES AND SUPPORTS MARKET DURING THE FORECAST PERIOD 53
4.6 ORTHOPEDIC BRACES AND SUPPORTS MARKET, BY REGION (2022) 54
FIGURE 17 APAC MARKET TO WITNESS THE HIGHEST GROWTH DURING THE FORECAST PERIOD (2022–2027) 54
5 MARKET OVERVIEW 55
5.1 INTRODUCTION 55
5.2 MARKET DYNAMICS 55
FIGURE 18 ORTHOPEDIC BRACES AND SUPPORTS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 55
5.2.1 DRIVERS 56
5.2.1.1 Increasing prevalence of orthopedic diseases and disorders 56
FIGURE 19 OBESE POPULATION (AS A PERCENTAGE OF THE TOTAL POPULATION) IN OECD COUNTRIES (2020) 56
5.2.1.2 Continuous product commercialization 57
5.2.1.3 Greater product affordability and market availability 57
5.2.1.4 Rising number of sports and accident-related injuries 58
FIGURE 20 INJURIES CAUSED BY VARIOUS SPORTS ACTIVITIES IN THE US (2020) 58
FIGURE 21 US REPORTED THE HIGHEST NUMBER OF ROAD ACCIDENTS
GLOBALLY (2018) 59
5.2.1.5 Growing public awareness about preventive care 59
5.2.2 RESTRAINTS 60
5.2.2.1 Limited patient qualification for bracing-mediated orthopedic treatment 60
5.2.2.2 Limited clinical evidence to support the therapeutic efficacy of orthopedic braces 60
5.2.3 OPPORTUNITIES 61
5.2.3.1 Increased sales of off-the-shelf and online products 61
5.2.3.2 Expansion and promotion initiatives undertaken by major product manufacturers 61
5.2.4 CHALLENGES 61
5.2.4.1 Significant adoption of pain medication 61
5.3 REIMBURSEMENT SCENARIO 62
TABLE 1 REIMBURSEMENT CODES FOR VARIOUS PROCEDURES (AS OF 2020) 62
5.4 KEY CONFERENCES & EVENTS IN 2022–2023 72
TABLE 2 ORTHOPEDIC BRACES AND SUPPORTS MARKET: DETAILED LIST OF CONFERENCES & EVENTS 72
5.5 REGULATORY LANDSCAPE 73
5.5.1 GLOBAL 73
5.5.2 EUROPE 74
5.5.3 US 75
5.5.4 JAPAN 75
TABLE 3 JAPAN MEDICAL DEVICE CLASSIFICATION UNDER PMDA 76
5.5.5 CHINA 76
TABLE 4 CHINA: CLASSIFICATION OF MEDICAL DEVICES 77
5.5.6 INDIA 78
5.6 PRICING TREND ANALYSIS 79
TABLE 5 AVERAGE PRICE OF ORTHOPEDIC BRACES AND SUPPORTS,
BY COUNTRY, 2021 (USD) 79
5.7 VALUE CHAIN ANALYSIS 80
FIGURE 22 VALUE CHAIN OF THE ORTHOPEDIC BRACES AND SUPPORTS MARKET 80
5.8 ECOSYSTEM ANALYSIS 81
5.9 PORTER’S FIVE FORCES ANALYSIS 81
TABLE 6 ORTHOPEDIC BRACES AND SUPPORTS MARKET: PORTER’S FIVE
FORCES ANALYSIS 81
5.9.1 THREAT FROM NEW ENTRANTS 82
FIGURE 23 THREAT FROM NEW ENTRANTS 82
5.9.2 THREAT FROM SUBSTITUTES 83
FIGURE 24 THREAT FROM SUBSTITUTES 83
5.9.3 BARGAINING POWER OF SUPPLIERS 83
FIGURE 25 BARGAINING POWER OF SUPPLIERS 83
5.9.4 BARGAINING POWER OF BUYERS 84
FIGURE 26 BARGAINING POWER OF BUYERS 84
5.9.5 INTENSITY OF COMPETITIVE RIVALRY 84
FIGURE 27 INTENSITY OF COMPETITIVE RIVALRY 85
5.10 KEY STAKEHOLDERS & BUYING CRITERIA 85
FIGURE 28 INFLUENCE OF STAKEHOLDERS IN THE BUYING PROCESS
FOR THE TOP THREE APPLICATIONS 85
TABLE 7 INFLUENCE OF STAKEHOLDERS IN THE BUYING PROCESS
FOR THE TOP THREE APPLICATIONS (%) 86
 
5.11 PATENT ANALYSIS 86
FIGURE 29 TOP 10 PATENT APPLICANTS FOR ORTHOPEDIC BRACES AND SUPPORTS (JANUARY 2012 TO FEBRUARY 2022) 86
FIGURE 30 NUMBER OF GRANTED PATENTS AND PATENT APPLICATIONS FILED (JANUARY 2012 TO FEBRUARY 2022) 87
FIGURE 31 PATENT DOCUMENTS FOR ORTHOPEDIC BRACES AND SUPPORTS, BY LEGAL STATUS (JANUARY 2012 TO FEBRUARY 2022) 87
FIGURE 32 REGIONAL ANALYSIS OF PATENTS GRANTED FOR ORTHOPEDIC BRACES AND SUPPORTS (JANUARY 2012 TO FEBRUARY 2022) 88
FIGURE 33 TOP 10 PATENT OWNERS IN THE LAST 10 YEARS 88
5.12 COVID-19-SPECIFIC TRENDS 88
6 ORTHOPEDIC BRACES AND SUPPORTS MARKET, BY PRODUCT 90
6.1 INTRODUCTION 91
TABLE 8 ORTHOPEDIC BRACES AND SUPPORTS MARKET, BY PRODUCT,
2020–2027 (USD MILLION) 91
6.2 KNEE BRACES AND SUPPORTS 91
6.2.1 THE RISING GERIATRIC POPULATION AND THE INCREASING NUMBER OF SPORTS INJURIES DRIVE THE MARKET GROWTH 91
TABLE 9 KNEE BRACES AND SUPPORTS MARKET, BY REGION,
2020–2027 (USD MILLION) 92
TABLE 10 KNEE BRACES AND SUPPORTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 92
TABLE 11 KNEE BRACES AND SUPPORTS MARKET, BY APPLICATION,
2020–2027 (USD MILLION) 93
TABLE 12 KNEE BRACES AND SUPPORTS MARKET, BY DISTRIBUTION CHANNEL,
2020–2027 (USD MILLION) 93
6.3 ANKLE BRACES AND SUPPORTS 94
6.3.1 HIGHER PREVALENCE OF ANKLE INJURIES AND RISING CASES OF ANKLE OSTEOARTHRITIS TO DRIVE THE MARKET GROWTH 94
TABLE 13 ANKLE BRACES AND SUPPORTS MARKET, BY REGION,
2020–2027 (USD MILLION) 94
TABLE 14 ANKLE BRACES AND SUPPORTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 95
TABLE 15 ANKLE BRACES AND SUPPORTS MARKET, BY APPLICATION,
2020–2027 (USD MILLION) 95
TABLE 16 ANKLE BRACES AND SUPPORTS MARKET, BY DISTRIBUTION CHANNEL, 2020–2027 (USD MILLION) 96
6.4 FOOT WALKERS AND ORTHOSES 96
6.4.1 THE DEMAND FOR FOOT WALKERS AND ORTHOSES IS INCREASING OWING TO THE RISING INCIDENCE OF DIABETES 96
TABLE 17 FOOT WALKERS AND ORTHOSES MARKET, BY REGION,
2020–2027 (USD MILLION) 97
TABLE 18 FOOT WALKERS AND ORTHOSES MARKET, BY TYPE,
2020–2027 (USD MILLION) 97
6.4.2 FOOT WALKERS AND ORTHOSES MARKET, BY APPLICATION 98
TABLE 19 FOOT WALKERS AND ORTHOSES MARKET, BY APPLICATION,
2020–2027 (USD MILLION) 98
6.4.3 FOOT WALKERS AND ORTHOSES MARKET, BY DISTRIBUTION CHANNEL 98
TABLE 20 FOOT WALKERS AND ORTHOSES MARKET, BY DISTRIBUTION CHANNEL, 2020–2027 (USD MILLION) 98
6.5 BACK, HIP, AND SPINE BRACES AND SUPPORTS 99
6.5.1 RISING INCIDENCE OF SPINAL AND HIP INJURIES DUE TO ROAD ACCIDENTS AND SPORTS INJURIES TO SUPPORT THE MARKET GROWTH 99
TABLE 21 BACK, HIP, AND SPINE BRACES AND SUPPORTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 99
TABLE 22 BACK, HIP, AND SPINE BRACES AND SUPPORTS MARKET, BY REGION, 2020–2027 (USD MILLION) 99
TABLE 23 BACK, HIP, AND SPINE BRACES AND SUPPORTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 100
TABLE 24 BACK, HIP, AND SPINE BRACES AND SUPPORTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 100
TABLE 25 BACK, HIP, AND SPINE BRACES AND SUPPORTS MARKET, BY DISTRIBUTION CHANNEL, 2020–2027 (USD MILLION) 101
6.5.2 NECK & CERVICAL BRACES AND SUPPORTS 101
6.5.2.1 Rising number of neck-related injuries to drive the
growth of this segment 101
TABLE 26 NECK & CERVICAL BRACES AND SUPPORTS MARKET, BY REGION,
2020–2027 (USD MILLION) 102
TABLE 27 NECK & CERVICAL BRACES AND SUPPORTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 102
TABLE 28 NECK & CERVICAL BRACES AND SUPPORTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 103
TABLE 29 NECK & CERVICAL BRACES AND SUPPORTS MARKET, BY DISTRIBUTION CHANNEL, 2020–2027 (USD MILLION) 103
6.5.3 LOWER SPINE BRACES AND SUPPORTS 104
6.5.3.1 Increasing prevalence of lower spine disorders to drive
the market growth 104
TABLE 30 LOWER SPINE BRACES AND SUPPORTS MARKET, BY REGION,
2020–2027 (USD MILLION) 104
TABLE 31 LOWER SPINE BRACES AND SUPPORTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 105
TABLE 32 LOWER SPINE BRACES AND SUPPORTS MARKET, BY APPLICATION,
2020–2027 (USD MILLION) 105
TABLE 33 LOWER SPINE BRACES AND SUPPORTS MARKET, BY DISTRIBUTION CHANNEL, 2020–2027 (USD MILLION) 106
6.6 SHOULDER BRACES AND SUPPORTS 106
6.6.1 GROWING DEMAND FOR SHOULDER REPLACEMENT PROCEDURES TO SUPPORT THE MARKET GROWTH 106
TABLE 34 SHOULDER BRACES AND SUPPORTS MARKET, BY REGION,
2020–2027 (USD MILLION) 107
TABLE 35 SHOULDER BRACES AND SUPPORTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 107
TABLE 36 SHOULDER BRACES AND SUPPORTS MARKET, BY APPLICATION,
2020–2027 (USD MILLION) 108
TABLE 37 GLOBAL SHOULDER BRACES AND SUPPORTS MARKET, BY DISTRIBUTION CHANNEL, 2020–2027 (USD MILLION) 108
6.7 ELBOW BRACES AND SUPPORTS 109
6.7.1 THE INCREASING NUMBER OF SPORTS INJURIES CREATE A HIGHER DEMAND FOR ELBOW BRACES & SUPPORTS 109
TABLE 38 ELBOW BRACES AND SUPPORTS MARKET, BY REGION,
2020–2027 (USD MILLION) 109
TABLE 39 ELBOW BRACES AND SUPPORTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 109
TABLE 40 ELBOW BRACES AND SUPPORTS MARKET, BY APPLICATION,
2020–2027 (USD MILLION) 110
TABLE 41 ELBOW BRACES AND SUPPORTS MARKET, BY DISTRIBUTION CHANNEL, 2020–2027 (USD MILLION) 110
6.8 HAND & WRIST BRACES AND SUPPORTS 111
6.8.1 HIGHER MARKET AVAILABILITY OF HAND & WRIST BRACES AND SUPPORTS TO DRIVE THE MARKET GROWTH 111
TABLE 42 HAND & WRIST BRACES AND SUPPORTS MARKET, BY REGION,
2020–2027 (USD MILLION) 111
TABLE 43 HAND & WRIST BRACES AND SUPPORTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 112
TABLE 44 HAND & WRIST BRACES AND SUPPORTS MARKET, BY APPLICATION,
2020–2027 (USD MILLION) 112
TABLE 45 HAND & WRIST BRACES AND SUPPORTS MARKET, BY DISTRIBUTION CHANNEL, 2020–2027 (USD MILLION) 113
6.9 FACIAL BRACES AND SUPPORTS 113
6.9.1 DEMAND FOR FACIAL RECONSTRUCTION SURGERIES AND RISING CONGENITAL CRANIAL DEFORMITIES TO DRIVE THE MARKET GROWTH 113
FIGURE 34 NUMBER OF PLASTIC SURGERY (FACIAL) PROCEDURES WORLDWIDE
(AS OF 2020) 114
TABLE 46 FACIAL BRACES AND SUPPORTS MARKET, BY REGION,
2020–2027 (USD MILLION) 114
TABLE 47 FACIAL BRACES AND SUPPORTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 114
TABLE 48 FACIAL BRACES AND SUPPORTS MARKET, BY APPLICATION,
2020–2027 (USD MILLION) 115
TABLE 49 FACIAL BRACES AND SUPPORTS MARKET, BY DISTRIBUTION CHANNEL, 2020–2027 (USD MILLION) 115
7 ORTHOPEDIC BRACES AND SUPPORTS MARKET, BY TYPE 116
7.1 INTRODUCTION 117
TABLE 50 ORTHOPEDIC BRACES AND SUPPORTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 117
7.2 SOFT & ELASTIC BRACES AND SUPPORTS 117
7.2.1 ADVANTAGES OF SOFT & ELASTIC BRACES AND SUPPORTS, SUCH AS EASE OF USE AND FLEXIBILITY, TO DRIVE MARKET GROWTH 117
TABLE 51 SOFT & ELASTIC ORTHOPEDIC BRACES AND SUPPORTS MARKET, BY REGION, 2020–2027 (USD MILLION) 118
7.3 HARD BRACES AND SUPPORTS 118
7.3.1 SUPPORTIVE REIMBURSEMENT SCENARIO AND RISING PREVALENCE
OF TARGET DISEASES TO DRIVE MARKET GROWTH 118
TABLE 52 HARD ORTHOPEDIC BRACES AND SUPPORTS MARKET, BY REGION,
2020–2027 (USD MILLION) 119
7.4 HINGED BRACES AND SUPPORTS 119
7.4.1 RISING GERIATRIC POPULATION AND THE INCREASING NUMBER OF LIGAMENT INJURIES—KEY FACTORS DRIVING MARKET GROWTH 119
TABLE 53 HINGED ORTHOPEDIC BRACES AND SUPPORTS MARKET, BY REGION,
2020–2027 (USD MILLION) 120
8 ORTHOPEDIC BRACES AND SUPPORTS MARKET, BY APPLICATION 121
8.1 INTRODUCTION 122
TABLE 54 ORTHOPEDIC BRACES AND SUPPORTS MARKET, BY APPLICATION,
2020–2027 (USD MILLION) 122
8.2 LIGAMENT INJURY 122
TABLE 55 ORTHOPEDIC BRACES AND SUPPORTS MARKET FOR LIGAMENT INJURY,
BY APPLICATION, 2020–2027 (USD MILLION) 123
TABLE 56 ORTHOPEDIC BRACES AND SUPPORTS MARKET FOR LIGAMENT INJURY,
BY REGION, 2020–2027 (USD MILLION) 123
8.2.1 ANTERIOR CRUCIATE LIGAMENT (ACL) INJURY 123
8.2.1.1 ACL injury applications to register the highest growth rate during the forecast period 123
TABLE 57 ORTHOPEDIC BRACES AND SUPPORTS MARKET FOR ACL INJURY, BY REGION, 2020–2027 (USD MILLION) 124
8.2.2 LATERAL COLLATERAL LIGAMENT (LCL) INJURY 124
8.2.2.1 Rising reimbursements of LCL-related surgical procedures to drive the market growth 124
TABLE 58 ORTHOPEDIC BRACES AND SUPPORTS MARKET FOR LCL INJURY, BY REGION, 2020–2027 (USD MILLION) 125
8.2.3 OTHER LIGAMENT INJURIES 125
TABLE 59 ORTHOPEDIC BRACES AND SUPPORTS MARKET FOR OTHER LIGAMENT INJURIES, BY REGION, 2020–2027 (USD MILLION) 125
8.3 PREVENTIVE CARE 126
8.3.1 INCREASING PUBLIC PARTICIPATION IN SPORTS-RELATED ACTIVITIES TO SUPPORT THE MARKET GROWTH 126
TABLE 60 ORTHOPEDIC BRACES AND SUPPORTS MARKET FOR PREVENTIVE CARE,
BY REGION, 2020–2027 (USD MILLION) 126
8.4 POST-OPERATIVE REHABILITATION 127
8.4.1 INCREASING NUMBER OF ORTHOPEDIC RECONSTRUCTIVE SURGERIES TO SUPPORT THE MARKET GROWTH 127
TABLE 61 ORTHOPEDIC BRACES AND SUPPORTS MARKET FOR POST-OPERATIVE REHABILITATION, BY REGION, 2020–2027 (USD MILLION) 127
8.5 OSTEOARTHRITIS 128
8.5.1 RISING OSTEOARTHRITIS CASES AND PUBLIC AWARENESS ON THE SIDE-EFFECTS OF ORAL MEDICATION FOR PAIN MANAGEMENT TO SUPPORT THE MARKET GROWTH 128
TABLE 62 ORTHOPEDIC BRACES AND SUPPORTS MARKET FOR OSTEOARTHRITIS,
BY REGION, 2020–2027 (USD MILLION) 128
 
8.6 COMPRESSION THERAPY 129
8.6.1 INNOVATION OF TECHNOLOGICALLY ADVANCED COMPRESSION BRACES TO SUPPORT THE MARKET GROWTH 129
TABLE 63 ORTHOPEDIC BRACES AND SUPPORTS MARKET FOR COMPRESSION THERAPY, BY REGION, 2020–2027 (USD MILLION) 129
8.7 OTHER APPLICATIONS 130
TABLE 64 ORTHOPEDIC BRACES AND SUPPORTS MARKET FOR OTHER APPLICATIONS, BY REGION, 2020–2027 (USD MILLION) 130
9 ORTHOPEDIC BRACES AND SUPPORTS MARKET, BY DISTRIBUTION CHANNEL 131
9.1 INTRODUCTION 132
TABLE 65 ORTHOPEDIC BRACES AND SUPPORTS MARKET, BY DISTRIBUTION CHANNEL, 2020–2027 (USD MILLION) 132
9.2 HOSPITALS AND SURGICAL CENTERS 132
9.2.1 INCREASING DEMAND FOR POST-OPERATIVE PATIENT REHABILITATION PROCEDURES TO SUPPORT THE GROWTH OF THIS SEGMENT 132
TABLE 66 ORTHOPEDIC BRACES AND SUPPORTS MARKET FOR HOSPITALS AND SURGICAL CENTERS, BY REGION, 2020–2027 (USD MILLION) 133
9.3 ORTHOPEDIC CLINICS 133
9.3.1 THE RISING NUMBER OF AMBULATORY CARE UNITS ACROSS MATURE MARKETS IS A MAJOR FACTOR SUPPORTING THE GROWTH OF THIS SEGMENT 133
TABLE 67 ORTHOPEDIC BRACES AND SUPPORTS MARKET FOR ORTHOPEDIC CLINICS, BY REGION, 2020–2027 (USD MILLION) 134
9.4 PHARMACIES & RETAILERS 134
9.4.1 WIDE AVAILABILITY OF ORTHOPEDIC BRACING PRODUCTS THROUGH RETAILERS & PHARMACIES TO SUPPORT THE GROWTH OF THIS SEGMENT 134
TABLE 68 ORTHOPEDIC BRACES AND SUPPORTS MARKET FOR PHARMACIES & RETAILERS, BY REGION, 2020–2027 (USD MILLION) 135
9.5 E-COMMERCE PLATFORMS 135
9.5.1 E-COMMERCE IS FAST EMERGING AS A MAJOR DISTRIBUTION CHANNEL FOR VARIOUS ORTHOPEDIC BRACING AND SUPPORT PRODUCTS 135
TABLE 69 ORTHOPEDIC BRACES AND SUPPORTS MARKET FOR E-COMMERCE PLATFORMS, BY REGION, 2020–2027 (USD MILLION) 136
9.6 OTHER END USERS 136
TABLE 70 ORTHOPEDIC BRACES AND SUPPORTS MARKET FOR OTHER END USERS,
BY REGION, 2020–2027 (USD MILLION) 136
10 ORTHOPEDIC BRACES AND SUPPORTS MARKET, BY REGION 137
10.1 INTRODUCTION 138
TABLE 71 ORTHOPEDIC BRACES AND SUPPORTS MARKET, BY REGION,
2020–2027 (USD MILLION) 138
10.2 NORTH AMERICA 138
FIGURE 35 NORTH AMERICA GEOGRAPHIC SNAPSHOT 139
TABLE 72 NORTH AMERICA: ORTHOPEDIC BRACES AND SUPPORTS MARKET,
BY COUNTRY, 2020–2027 (USD MILLION) 140
TABLE 73 NORTH AMERICA: ORTHOPEDIC BRACES AND SUPPORTS MARKET,
BY PRODUCT, 2020–2027 (USD MILLION) 140
TABLE 74 NORTH AMERICA: BACK, HIP, AND SPINE BRACES AND SUPPORTS MARKET, BY TYPE, 2020–2027 (USD MILLION) 141
TABLE 75 NORTH AMERICA: ORTHOPEDIC BRACES AND SUPPORTS MARKET,
BY TYPE, 2020–2027 (USD MILLION) 141
TABLE 76 NORTH AMERICA: ORTHOPEDIC BRACES AND SUPPORTS MARKET,
BY APPLICATION, 2020–2027 (USD MILLION) 142
TABLE 77 NORTH AMERICA: ORTHOPEDIC BRACES AND SUPPORTS MARKET,
BY DISTRIBUTION CHANNEL, 2020–2027 (USD MILLION) 142
10.2.1 US 143
10.2.1.1 Increasing number of sports-related injuries and the strong presence of market players in the country drive the market growth 143
TABLE 78 US: ORTHOPEDIC BRACES AND SUPPORTS MARKET, BY PRODUCT,
2020–2027 (USD MILLION) 143
TABLE 79 US: BACK, HIP, AND SPINE BRACES AND SUPPORTS MARKET, BY TYPE, 2020–2027 (USD MILLION) 144
10.2.2 CANADA 144
10.2.2.1 Market growth in Canada is largely driven by the rising incidence of bone-related degenerative diseases 144
TABLE 80 CANADA: ORTHOPEDIC BRACES AND SUPPORTS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 145
TABLE 81 CANADA: BACK, HIP, AND SPINE BRACES AND SUPPORTS MARKET, BY TYPE, 2020–2027 (USD MILLION) 145
10.3 EUROPE 146
TABLE 82 EUROPE: ORTHOPEDIC BRACES AND SUPPORTS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 146
TABLE 83 EUROPE: ORTHOPEDIC BRACES AND SUPPORTS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 147
TABLE 84 EUROPE: BACK, HIP, AND SPINE BRACES AND SUPPORTS MARKET, BY TYPE, 2020–2027 (USD MILLION) 147
TABLE 85 EUROPE: ORTHOPEDIC BRACES AND SUPPORTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 148
TABLE 86 EUROPE: ORTHOPEDIC BRACES AND SUPPORTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 148
TABLE 87 EUROPE: ORTHOPEDIC BRACES AND SUPPORTS MARKET, BY DISTRIBUTION CHANNEL, 2020–2027 (USD MILLION) 149
10.3.1 GERMANY 149
10.3.1.1 The rising geriatric population in Germany ensures the continuous demand for orthopedic braces & supports 149
TABLE 88 PRODUCT LAUNCHES IN GERMANY, 2019–2022 150
TABLE 89 GERMANY: ORTHOPEDIC BRACES AND SUPPORTS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 150
TABLE 90 GERMANY: BACK, HIP, AND SPINE BRACES AND SUPPORTS MARKET,
BY TYPE, 2020–2027 (USD MILLION) 151
10.3.2 UK 151
10.3.2.1 The increasing number of sports injuries mainly drives the market growth in the UK 151
TABLE 91 UK: ORTHOPEDIC BRACES AND SUPPORTS MARKET, BY PRODUCT,
2020–2027 (USD MILLION) 152
TABLE 92 UK: BACK, HIP, AND SPINE BRACES AND SUPPORTS MARKET,
BY TYPE, 2020–2027 (USD MILLION) 152
10.3.3 FRANCE 153
10.3.3.1 The growing prevalence of musculoskeletal injuries drives the market growth for braces & supports in France 153
TABLE 93 FRANCE: ORTHOPEDIC BRACES AND SUPPORTS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 153
TABLE 94 FRANCE: BACK, HIP, AND SPINE BRACES AND SUPPORTS MARKET, BY TYPE, 2020–2027 (USD MILLION) 154
10.3.4 ITALY 154
10.3.4.1 Increasing public awareness on preventive care for musculoskeletal injuries to drive the market growth 154
TABLE 95 ITALY: ORTHOPEDIC BRACES AND SUPPORTS MARKET, BY PRODUCT,
2020–2027 (USD MILLION) 155
TABLE 96 ITALY: BACK, HIP, AND SPINE BRACES AND SUPPORTS MARKET,
BY TYPE, 2020–2027 (USD MILLION) 155
10.3.5 SPAIN 156
10.3.5.1 Increasing market availability of orthopedic braces & supports to drive the market growth 156
TABLE 97 SPAIN: ORTHOPEDIC BRACES AND SUPPORTS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 156
TABLE 98 SPAIN: BACK, HIP, AND SPINE BRACES AND SUPPORTS MARKET, BY TYPE, 2020–2027 (USD MILLION) 157
10.3.6 REST OF EUROPE 157
TABLE 99 ROE: ORTHOPEDIC BRACES AND SUPPORTS MARKET, BY PRODUCT,
2020–2027 (USD MILLION) 158
TABLE 100 ROE: BACK, HIP, AND SPINE BRACES AND SUPPORTS MARKET,
BY TYPE, 2020–2027 (USD MILLION) 158
10.4 ASIA PACIFIC 159
FIGURE 36 APAC GEOGRAPHIC SNAPSHOT 160
TABLE 101 ASIA PACIFIC: ORTHOPEDIC BRACES AND SUPPORTS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 161
TABLE 102 ASIA PACIFIC: ORTHOPEDIC BRACES AND SUPPORTS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 161
TABLE 103 ASIA PACIFIC: BACK, HIP, AND SPINE BRACES AND SUPPORTS MARKET,
BY TYPE, 2020–2027 (USD MILLION) 162
TABLE 104 ASIA PACIFIC: ORTHOPEDIC BRACES AND SUPPORTS MARKET, BY TYPE, 2020–2027 (USD MILLION) 162
TABLE 105 ASIA PACIFIC: ORTHOPEDIC BRACES AND SUPPORTS MARKET,
BY APPLICATION, 2020–2027 (USD MILLION) 163
TABLE 106 ASIA PACIFIC: ORTHOPEDIC BRACES AND SUPPORTS MARKET,
BY DISTRIBUTION CHANNEL, 2020–2027 (USD MILLION) 163
10.4.1 JAPAN 164
10.4.1.1 Japan dominates the Asia Pacific orthopedic braces and
supports market 164
TABLE 107 JAPAN: ORTHOPEDIC BRACES AND SUPPORTS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 164
TABLE 108 JAPAN: BACK, HIP, AND SPINE BRACES AND SUPPORTS MARKET,
BY TYPE, 2020–2027 (USD MILLION) 165
10.4.2 CHINA 165
10.4.2.1 Expanding target patient population and modernization of healthcare facilities in China to drive market growth 165
TABLE 109 CHINA: ORTHOPEDIC BRACES AND SUPPORTS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 166
TABLE 110 CHINA: BACK, HIP, AND SPINE BRACES AND SUPPORTS MARKET,
BY TYPE, 2020–2027 (USD MILLION) 166
10.4.3 INDIA 167
10.4.3.1 Growing number of hip & knee surgeries to support the market growth in India 167
TABLE 111 INDIA: ORTHOPEDIC BRACES AND SUPPORTS MARKET, BY PRODUCT,
2020–2027 (USD MILLION) 167
TABLE 112 INDIA: BACK, HIP, AND SPINE BRACES AND SUPPORTS MARKET, BY TYPE, 2020–2027 (USD MILLION) 168
10.4.4 SOUTH KOREA 168
10.4.4.1 Rising geriatric population and the growing number of reconstructive surgeries to support market growth in South Korea 168
TABLE 113 SOUTH KOREA: ORTHOPEDIC BRACES AND SUPPORTS MARKET,
BY PRODUCT, 2020–2027 (USD MILLION) 169
TABLE 114 SOUTH KOREA: BACK, HIP, AND SPINE BRACES AND SUPPORTS MARKET,
BY TYPE, 2020–2027 (USD MILLION) 169
10.4.5 AUSTRALIA 170
10.4.5.1 Increasing incidence of musculoskeletal disorders supports the growth of orthopedic braces and supports market 170
TABLE 115 AUSTRALIA: ORTHOPEDIC BRACES AND SUPPORTS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 170
TABLE 116 AUSTRALIA: BACK, HIP, AND SPINE BRACES AND SUPPORTS MARKET,
BY TYPE, 2020–2027 (USD MILLION) 171
10.4.6 REST OF ASIA PACIFIC 171
TABLE 117 ROAPAC: ORTHOPEDIC BRACES AND SUPPORTS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 172
TABLE 118 ROAPAC: BACK, HIP, AND SPINE BRACES AND SUPPORTS MARKET,
BY TYPE, 2020–2027 (USD MILLION) 172
10.5 LATIN AMERICA 173
TABLE 119 LATIN AMERICA: ORTHOPEDIC BRACES AND SUPPORTS MARKET,
BY COUNTRY, 2020–2027 (USD MILLION) 173
TABLE 120 LATIN AMERICA: ORTHOPEDIC BRACES AND SUPPORTS MARKET,
BY PRODUCT, 2020–2027 (USD MILLION) 174
TABLE 121 LATIN AMERICA: BACK, HIP, AND SPINE BRACES AND SUPPORTS MARKET, BY TYPE, 2020–2027 (USD MILLION) 174
TABLE 122 LATIN AMERICA: ORTHOPEDIC BRACES AND SUPPORTS MARKET,
BY TYPE, 2020–2027 (USD MILLION) 175
TABLE 123 LATIN AMERICA: ORTHOPEDIC BRACES AND SUPPORTS MARKET,
BY APPLICATION, 2020–2027 (USD MILLION) 175
TABLE 124 LATIN AMERICA: ORTHOPEDIC BRACES AND SUPPORTS MARKET,
BY DISTRIBUTION CHANNEL, 2020–2027 (USD MILLION) 176
10.5.1 BRAZIL 176
10.5.1.1 Growth in the middle-class population and its purchasing power enables easier access to orthopedic braces and supports 176
TABLE 125 BRAZIL: ORTHOPEDIC BRACES AND SUPPORTS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 177
TABLE 126 BRAZIL: BACK, HIP, AND SPINE BRACES AND SUPPORTS MARKET,
BY TYPE, 2020–2027 (USD MILLION) 177
10.5.2 MEXICO 178
10.5.2.1 Increasing obese and diabetic populations in Mexico to
drive market growth 178
TABLE 127 MEXICO: ORTHOPEDIC BRACES AND SUPPORTS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 178
TABLE 128 MEXICO: BACK, HIP, AND SPINE BRACES AND SUPPORTS MARKET,
BY TYPE, 2020–2027 (USD MILLION) 179
10.5.3 REST OF LATIN AMERICA 179
TABLE 129 ROLATAM: ORTHOPEDIC BRACES AND SUPPORTS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 180
TABLE 130 ROLATAM: BACK, HIP, AND SPINE BRACES AND SUPPORTS MARKET,
BY TYPE, 2020–2027 (USD MILLION) 180
10.6 MIDDLE EAST & AFRICA 181
TABLE 131 MEA: ORTHOPEDIC BRACES AND SUPPORTS MARKET, BY PRODUCT,
2020–2027 (USD MILLION) 181
TABLE 132 MEA: BACK, HIP, AND SPINE BRACES AND SUPPORTS MARKET,
BY TYPE, 2020–2027 (USD MILLION) 182
TABLE 133 MEA: ORTHOPEDIC BRACES AND SUPPORTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 182
TABLE 134 MEA: ORTHOPEDIC BRACES AND SUPPORTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 183
TABLE 135 MEA: ORTHOPEDIC BRACES AND SUPPORTS MARKET, BY DISTRIBUTION CHANNEL, 2020–2027 (USD MILLION) 183
11 COMPETITIVE LANDSCAPE 184
11.1 INTRODUCTION 184
11.2 KEY PLAYER STRATEGIES 184
11.3 REVENUE SHARE ANALYSIS OF THE TOP MARKET PLAYERS 185
11.4 MARKET SHARE ANALYSIS (2021) 185
TABLE 136 ORTHOPEDIC BRACES AND SUPPORTS MARKET: DEGREE OF COMPETITION 185
11.5 COMPANY EVALUATION QUADRANT 187
11.5.1 STARS 187
11.5.2 PERVASIVE PLAYERS 187
11.5.3 EMERGING LEADERS 187
11.5.4 PARTICIPANTS 187
FIGURE 38 ORTHOPEDIC BRACES AND SUPPORTS MARKET: COMPETITIVE LEADERSHIP MAPPING, 2021 188
 
11.6 START-UPS/SMES EVALUATION QUADRANT 189
11.6.1 PROGRESSIVE COMPANIES 189
11.6.2 STARTING BLOCKS 189
11.6.3 RESPONSIVE COMPANIES 189
11.6.4 DYNAMIC COMPANIES 189
FIGURE 39 ORTHOPEDIC AND SUPPORTS MARKET: COMPETITIVE
LEADERSHIP MAPPING FOR START-UPS/SMES, 2021 190
11.7 COMPETITIVE BENCHMARKING OF THE TOP PLAYERS IN
THE ORTHOPEDIC AND SUPPORTS MARKET 191
11.7.1 PRODUCT AND REGIONAL FOOTPRINT ANALYSIS OF THE TOP PLAYERS IN THE ORTHOPEDIC BRACES AND SUPPORTS MARKET 191
TABLE 137 PRODUCT FOOTPRINT OF COMPANIES 192
TABLE 138 REGIONAL FOOTPRINT OF COMPANIES 193
11.8 COMPETITIVE BENCHMARKING (STARTUP/SMES) 194
TABLE 139 PRODUCT MAPPING OF KEY STARTUP/SMES 195
TABLE 140 APPLICATION AND GEOGRAPHY MAPPING OF KEY STARTUP/SMES 196
11.9 COMPETITIVE SCENARIO 197
11.9.1 ORTHOPEDIC BRACES AND SUPPORTS MARKET:
PRODUCT LAUNCHES AND REGULATORY APPROVALS 197
TABLE 141 KEY PRODUCT LAUNCHES AND REGULATORY APPROVALS,
JANUARY 2018–JANUARY 2022 197
11.9.2 ORTHOPEDIC AND SUPPORTS MARKET: DEALS 198
TABLE 142 KEY DEALS, JANUARY 2018–JANUARY 2022 198
11.9.3 ORTHOPEDIC AND SUPPORTS MARKET: OTHER DEVELOPMENTS 199
TABLE 143 OTHER KEY DEVELOPMENTS, JANUARY 2018–JANUARY 2022 199
12 COMPANY PROFILES 200
12.1 MAJOR PLAYERS 200
(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
12.1.1 3M COMPANY 200
TABLE 144 3M COMPANY: BUSINESS OVERVIEW 200
FIGURE 40 3M: COMPANY SNAPSHOT (2021) 201
12.1.2 ESSITY (BSN MEDICAL AND FLA ORTHOPEDIC) 206
TABLE 145 ESSITY: BUSINESS OVERVIEW 206
FIGURE 41 ESSITY: COMPANY SNAPSHOT (2021) 207
12.1.3 ZIMMER BIOMET HOLDINGS, INC. 214
TABLE 146 ZIMMER BIOMET: BUSINESS OVERVIEW 214
FIGURE 42 ZIMMER BIOMET: COMPANY SNAPSHOT (2021) 215
12.1.4 DJO FINANCE LLC (A SUBSIDIARY OF COLFAX CORPORATION) 217
TABLE 147 DJO FINANCE LLC: BUSINESS OVERVIEW 217
FIGURE 43 DJO FINANCE LLC: COMPANY SNAPSHOT (2020) 218
12.1.5 OTTOBOCK HEALTHCARE (A PART OF OTTOBOCK GROUP SCANDINAVIA) 233
TABLE 148 OTTOBOCK HEALTHCARE: BUSINESS OVERVIEW 233
12.1.6 ÖSSUR HF 242
TABLE 149 OSSUR HF: BUSINESS OVERVIEW 242
FIGURE 44 OSSUR HF: COMPANY SNAPSHOT (2021) 243
12.1.7 THUASNE GROUP 249
TABLE 150 THUASNE GROUP: BUSINESS OVERVIEW 249
12.1.8 ALCARE CO., LTD. 259
TABLE 151 ALCARE CO., LTD.: BUSINESS OVERVIEW 259
12.1.9 NIPPON SIGMAX CO., LTD. 260
TABLE 152 NIPPON SIGMAX CO., LTD.: BUSINESS OVERVIEW 260
12.1.10 BIRD & CRONIN INC. (A PART OF DYNATRONICS CORPORATION) 264
TABLE 153 BIRD & CRONIN INC.: BUSINESS OVERVIEW 264
FIGURE 45 BIRD & CRONIN: COMPANY SNAPSHOT (2021) 265
12.1.11 BAUERFEIND AG 274
TABLE 154 BAUERFEIND AG: BUSINESS OVERVIEW 274
12.1.12 BREG INC. (A PART OF WATER STREET HEALTHCARE PARTNERS) 278
TABLE 155 BREG INC: BUSINESS OVERVIEW 278
12.1.13 DEROYAL INDUSTRIES, INC. 290
TABLE 156 DEROYAL INDUSTRIES, INC.: BUSINESS OVERVIEW 290
12.1.14 MEDI GMBH & CO. KG 300
TABLE 157 MEDI GMBH & CO. KG: BUSINESS OVERVIEW 300
12.1.15 FOUNDATION WELLNESS (FORMERLY KNOWN AS
REMINGTON PRODUCTS COMPANY) 305
TABLE 158 FOUNDATION WELLNESS: BUSINESS OVERVIEW 305
12.1.16 TRULIFE GROUP LTD 308
TABLE 159 TRULIFE: BUSINESS OVERVIEW 308
12.1.17 MCDAVID, INC. (A PART OF SHOCK DOCTOR) 311
TABLE 160 MCDAVID, INC.: BUSINESS OVERVIEW 311
12.1.18 MUELLER SPORTS MEDICINE, INC. 315
TABLE 161 MUELLER SPORTS MEDICINE, INC.: BUSINESS OVERVIEW 315
12.1.19 BECKER ORTHOPEDIC 317
TABLE 162 BECKER ORTHOPEDIC: BUSINESS OVERVIEW 317
12.1.20 ORLIMAN S.L.U (A PART OF MAGNUM INDUSTRIAL PARTNERS) 319
TABLE 163 ORLIMAN S.L.U: BUSINESS OVERVIEW 319
12.2 OTHER EMERGING PLAYERS 324
12.2.1 MODERN MEDICAL AIDS 324
12.2.2 ASPEN MEDICAL PRODUCTS LLC 326
12.2.3 DARCO INTERNATIONAL, INC. 327
12.2.4 UNITED MEDICARE 328
12.2.5 VISSCO REHABILITATION AIDS PVT. LTD. 328
*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.
13 APPENDIX 330
13.1 DISCUSSION GUIDE 330
13.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 337
13.3 AVAILABLE CUSTOMIZATIONS 339
13.4 RELATED REPORTS 340
13.5 AUTHOR DETAILS 342

Lateral Flow Assay Components Market by Type, Application Type (Clinical Testing (Infectious, Cardiac Marker Test) Veterinary, Food Safety), Technique...

Publisher:        MarketsandMarkets

# of Pages:        224

Rating: 

1 User License $4,950

Publication Date:  April, 2022

Price:       $4,950 / User License




1 INTRODUCTION 33
1.1 OBJECTIVES OF THE STUDY 33
1.2 MARKET DEFINITION 33
1.2.1 CATEGORY-WISE INCLUSIONS AND EXCLUSIONS
IN THE LATERAL FLOW ASSAY COMPONENTS MARKET 33
1.3 MARKET SCOPE 34
1.3.1 MARKETS COVERED 34
FIGURE 1 LATERAL FLOW ASSAY COMPONENTS MARKET SEGMENTATION 34
1.3.2 YEARS CONSIDERED FOR THE STUDY 35
1.4 CURRENCY 35
TABLE 1 EXCHANGE RATES UTILIZED FOR CONVERSION TO USD 35
1.5 STAKEHOLDERS 35
2 RESEARCH METHODOLOGY 36
2.1 RESEARCH APPROACH 36
FIGURE 2 RESEARCH DESIGN 36
2.1.1 SECONDARY DATA 36
2.1.1.1 Key data from secondary sources 37
2.1.2 PRIMARY DATA 38
2.1.2.1 Primary sources 38
2.1.2.2 Key data from primary sources 39
2.1.2.3 Breakdown of primaries 39
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS (SUPPLY SIDE):
BY COMPANY TYPE, DESIGNATION, AND REGION 39
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS (DEMAND SIDE): BY END USER, DESIGNATION, AND REGION 40
2.2 MARKET SIZE ESTIMATION 40
FIGURE 5 MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS (2021) 41
FIGURE 6 SUPPLY-SIDE ANALYSIS: LATERAL FLOW ASSAY COMPONENTS MARKET (2021) 42
2.3 MARKET BREAKDOWN & DATA TRIANGULATION 44
FIGURE 7 DATA TRIANGULATION METHODOLOGY 45
2.4 KEY INDUSTRY INSIGHTS 46
2.5 LIMITATIONS 46
2.5.1 METHODOLOGY-RELATED LIMITATIONS 46
2.6 RISK ASSESSMENT 47
2.7 ASSUMPTIONS FOR THE STUDY 47
 
3 EXECUTIVE SUMMARY 48
FIGURE 8 LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2022 VS. 2027 (USD MILLION) 48
FIGURE 9 LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE,
2022 VS. 2027 (USD MILLION) 49
FIGURE 10 LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION,
2022 VS. 2027 (USD MILLION) 50
FIGURE 11 LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2022 VS. 2027 (USD MILLION) 51
FIGURE 12 GEOGRAPHICAL SNAPSHOT OF THE LATERAL FLOW ASSAY COMPONENTS MARKET 52
4 PREMIUM INSIGHTS 53
4.1 LATERAL FLOW ASSAY COMPONENTS MARKET OVERVIEW 53
FIGURE 13 RISING NUMBER OF LOCAL MANUFACTURERS FOR COMPONENTS IS DRIVING THE GROWTH OF THE LATERAL FLOW ASSAY COMPONENTS MARKET 53
4.2 REGIONAL MIX: LATERAL FLOW ASSAY COMPONENTS MARKET 54
FIGURE 14 APAC TO REGISTER THE HIGHEST CAGR DURING THE FORECAST PERIOD 54
4.3 ASIA PACIFIC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE AND COUNTRY 55
FIGURE 15 MEMBRANES ACCOUNTED FOR THE LARGEST SHARE OF THE ASIA PACIFIC MARKET IN 2021 55
4.4 LATERAL FLOW ASSAY COMPONENTS MARKET: GEOGRAPHICAL GROWTH OPPORTUNITIES 56
4.5 LATERAL FLOW ASSAY COMPONENTS MARKET: DEVELOPED VS. DEVELOPING COUNTRIES 56
5 MARKET OVERVIEW 57
5.1 INTRODUCTION 57
5.2 MARKET DYNAMICS: IMPACT ANALYSIS 57
5.2.1 DRIVERS 58
5.2.1.1 Growing demand for lateral flow assay kits due
to the COVID-19 pandemic 58
5.2.1.2 Growing usage of home-based lateral flow assay devices 58
5.2.1.3 Growing demand for point-of-care testing 58
5.2.1.4 Increasing public-private investments to develop lateral flow assays 59
5.2.2 RESTRAINTS 59
5.2.2.1 Availability of alternative diagnostic technologies 59
5.2.3 OPPORTUNITIES 59
5.2.3.1 Evolving applications of lateral flow assays 59
5.2.4 CHALLENGES 60
5.2.4.1 Requirement of specialized storage and shipping facilities for membranes 60
5.3 ASSESSMENT OF THE IMPACT OF COVID-19 ON THE ECONOMIC SCENARIO IN THE LATERAL FLOW ASSAY COMPONENTS MARKET 60
5.4 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES (YC-YCC) IN THE LATERAL FLOW ASSAY COMPONENTS MARKET 60
FIGURE 16 YC–YCC SHIFT IN THE LATERAL FLOW ASSAY COMPONENTS MARKET 61
5.5 AVERAGE SELLING PRICE TREND 61
TABLE 2 AVERAGE SELLING PRICE OF LATERAL FLOW ASSAY COMPONENTS,
BY REGION, 2021 (USD) 61
5.6 ECOSYSTEM MARKET MAP 62
FIGURE 17 ECOSYSTEM: LATERAL FLOW ASSAY COMPONENTS MARKET (2021) 62
5.7 PATENT ANALYSIS 63
5.7.1 PATENT PUBLICATION TRENDS FOR LATERAL FLOW ASSAYS 63
FIGURE 18 GLOBAL PATENT PUBLICATION TRENDS IN THE LATERAL FLOW ASSAY COMPONENTS MARKET, 2016–2021 64
5.7.2 JURISDICTION ANALYSIS: TOP APPLICANTS (COUNTRIES) FOR PATENTS IN THE LATERAL FLOW ASSAY COMPONENTS MARKET 64
FIGURE 19 JURISDICTION ANALYSIS: TOP APPLICANT COUNTRIES FOR LATERAL FLOW ASSAYS COMPONENTS, 2016–2021 64
5.8 VALUE CHAIN ANALYSIS 65
5.9 REGULATORY LANDSCAPE 66
TABLE 3 REGULATORY STANDARDS/APPROVALS REQUIRED FOR LATERAL FLOW IMMUNOASSAY PRODUCTS, BY COUNTRY/REGION 66
5.9.1 NORTH AMERICA 66
5.9.2 EUROPE 67
5.9.3 ASIA PACIFIC 67
5.9.3.1 India 67
5.9.3.2 China 67
5.9.3.3 Japan 68
5.10 TECHNOLOGY ANALYSIS 69
5.10.1 KEY TECHNOLOGY: LATERAL FLOW ASSAYS 69
5.11 KEY CONFERENCES & EVENTS DURING 2021–2023 69
TABLE 4 LATERAL FLOW ASSAY COMPONENTS MARKET: DETAILED LIST OF CONFERENCES & EVENTS 69
5.12 KEY STAKEHOLDERS & BUYING CRITERIA 70
5.12.1 KEY STAKEHOLDERS IN THE BUYING PROCESS 70
FIGURE 20 INFLUENCE OF STAKEHOLDERS IN THE BUYING PROCESS FOR THE TOP 3 APPLICATIONS 70
TABLE 5 INFLUENCE OF STAKEHOLDERS IN THE BUYING PROCESS FOR THE TOP 3 APPLICATIONS 70
5.12.2 BUYING CRITERIA 71
FIGURE 21 KEY BUYING CRITERIA FOR THE TOP 3 APPLICATIONS 71
TABLE 6 KEY BUYING CRITERIA FOR THE TOP 3 APPLICATIONS 71
5.13 PORTER’S FIVE FORCES ANALYSIS 72
TABLE 7 LATERAL FLOW ASSAY COMPONENTS MARKET:
PORTER’S FIVE FORCES ANALYSIS 72
5.13.1 THREAT FROM NEW ENTRANTS 72
5.13.2 THREAT FROM SUBSTITUTES 72
5.13.3 BARGAINING POWER OF BUYERS 73
5.13.4 BARGAINING POWER OF SUPPLIERS 73
5.13.5 INTENSITY OF COMPETITIVE RIVALRY 73
6 LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE 74
6.1 INTRODUCTION 75
TABLE 8 LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 75
6.2 MEMBRANES 75
TABLE 9 LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE,
2020–2027 (USD MILLION) 76
TABLE 10 LATERAL FLOW ASSAY COMPONENTS MARKET FOR MEMBRANES,
BY COUNTRY, 2020–2027 (USD MILLION) 76
6.2.1 NITROCELLULOSE MEMBRANES 77
6.2.1.1 Advantages of nitrocellulose membranes such as high protein-binding affinity and compatibility with a wide range of detection methods to drive market growth 77
TABLE 11 LATERAL FLOW ASSAY COMPONENTS MARKET FOR NITROCELLULOSE MEMBRANES, BY COUNTRY, 2020–2027 (USD MILLION) 77
TABLE 12 LATERAL FLOW ASSAY COMPONENTS MARKET FOR NITROCELLULOSE MEMBRANES (1 X 1 M SHEETS), BY REGION, 2020–2027 (IN THOUSANDS) 78
TABLE 13 LATERAL FLOW ASSAY COMPONENTS MARKET FOR NITROCELLULOSE MEMBRANES (20 MM X 1 M ROLLS), BY REGION, 2020–2027 (IN MILLIONS) 78
6.2.2 OTHER MEMBRANES 78
TABLE 14 LATERAL FLOW ASSAY COMPONENTS MARKET FOR OTHER MEMBRANES,
BY COUNTRY, 2020–2027 (USD MILLION) 79
6.3 PADS 80
TABLE 15 EXAMPLES OF DIFFERENT MATERIALS USED IN MANUFACTURING LATERAL FLOW ASSAY PADS 80
TABLE 16 LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 80
TABLE 17 LATERAL FLOW ASSAY COMPONENTS MARKET FOR PADS, BY COUNTRY, 2020–2027 (USD MILLION) 81
6.3.1 SAMPLE PADS 81
6.3.1.1 Ability to promote even and controlled distribution of samples to drive market growth 81
TABLE 18 LATERAL FLOW ASSAY COMPONENTS MARKET FOR SAMPLE PADS,
BY COUNTRY, 2020–2027 (USD MILLION) 82
6.3.2 CONJUGATE PADS 82
6.3.2.1 Conjugate pads play an important role in controlling the performance of lateral flow immunoassays 82
TABLE 19 LATERAL FLOW ASSAY COMPONENTS MARKET FOR CONJUGATE PADS,
BY COUNTRY, 2020–2027 (USD MILLION) 83
6.3.3 ABSORBENT PADS 84
6.3.3.1 Absorbent pads prevent backflow—a key factor driving market growth 84
TABLE 20 LATERAL FLOW ASSAY COMPONENTS MARKET FOR ABSORBENT PADS,
BY COUNTRY, 2020–2027 (USD MILLION) 84
6.4 OTHER COMPONENTS 84
TABLE 21 OTHER LATERAL FLOW ASSAY COMPONENTS MARKET, BY COUNTRY,
2020–2027 (USD MILLION) 85
7 LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION 86
7.1 INTRODUCTION 87
TABLE 22 LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION,
2020–2027 (USD MILLION) 87
7.2 CLINICAL TESTING 87
TABLE 23 LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 88
TABLE 24 LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING APPLICATIONS,
BY COUNTRY, 2020–2027 (USD MILLION) 88
7.2.1 INFECTIOUS DISEASE TESTING 89
7.2.1.1 Rising demand for infectious disease testing in emerging markets to drive market growth 89
TABLE 25 LATERAL FLOW ASSAY COMPONENTS MARKET FOR INFECTIOUS DISEASE TESTING, BY COUNTRY, 2020–2027 (USD MILLION) 89
7.2.2 PREGNANCY & FERTILITY TESTING 90
7.2.2.1 Growing infertility levels due to changing lifestyles—a key factor driving market growth 90
TABLE 26 LATERAL FLOW ASSAY COMPONENTS MARKET FOR PREGNANCY & FERTILITY TESTING, BY COUNTRY, 2020–2027 (USD MILLION) 90
7.2.3 CARDIAC MARKER TESTING 91
7.2.3.1 Rising prevalence of cardiovascular diseases and growing government support to drive growth in this market segment 91
TABLE 27 LATERAL FLOW ASSAY COMPONENTS MARKET FOR CARDIAC MARKER TESTING, BY COUNTRY, 2020–2027 (USD MILLION) 92
7.2.4 CHOLESTEROL TESTING/LIPID PROFILING 92
7.2.4.1 Growing prevalence of obesity and CVD—
a key factor driving market growth 92
TABLE 28 LATERAL FLOW ASSAY COMPONENTS MARKET FOR CHOLESTEROL TESTING/LIPID PROFILING, BY COUNTRY, 2020–2027 (USD MILLION) 93
7.2.5 DRUGS-OF-ABUSE TESTING 93
7.2.5.1 Technological advancements and a growing focus on workplace
drug testing are driving market growth 93
TABLE 29 LATERAL FLOW ASSAY COMPONENTS MARKET FOR DRUGS-OF-ABUSE TESTING, BY COUNTRY, 2020–2027 (USD MILLION) 94
7.2.6 OTHER CLINICAL TESTING APPLICATIONS 94
TABLE 30 LATERAL FLOW ASSAY COMPONENTS MARKET FOR OTHER CLINICAL TESTING APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION) 95
7.3 VETERINARY DIAGNOSTICS 95
7.3.1 INFECTIOUS DISEASE OUTBREAKS (PARTICULARLY IN LARGE LIVESTOCK ANIMALS) TO DRIVE MARKET GROWTH 95
TABLE 31 LATERAL FLOW ASSAY COMPONENTS MARKET FOR VETERINARY DIAGNOSTIC APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION) 96
7.4 FOOD SAFETY & ENVIRONMENTAL TESTING 96
7.4.1 HIGH SENSITIVITY AND EASE OF USE ARE KEY FACTORS DRIVING THE DEMAND FOR LATERAL FLOW ASSAYS FOR FOOD SAFETY TESTING 96
TABLE 32 LATERAL FLOW ASSAY COMPONENTS MARKET FOR FOOD SAFETY & ENVIRONMENTAL TESTING APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION) 97
7.5 DRUG DEVELOPMENT & QUALITY TESTING 97
7.5.1 INCREASING FOCUS ON PRODUCT SAFETY AND QUALITY ASSURANCE TO DRIVE MARKET GROWTH IN THE COMING YEARS 97
TABLE 33 LATERAL FLOW ASSAY COMPONENTS MARKET FOR DRUG DEVELOPMENT & QUALITY TESTING APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION) 98
8 LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE 99
8.1 INTRODUCTION 100
TABLE 34 LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE,
2020–2027 (USD MILLION) 100
8.2 SANDWICH ASSAYS 100
8.2.1 SANDWICH ASSAYS PROVIDE HIGHER LEVELS OF ASSAY SENSITIVITY AND SPECIFICITY THAN OTHER ASSAY TECHNIQUES—A KEY FACTOR DRIVING GROWTH IN THIS MARKET SEGMENT 100
TABLE 35 LATERAL FLOW ASSAY COMPONENTS MARKET FOR SANDWICH ASSAYS,
BY COUNTRY, 2020–2027 (USD MILLION) 101
8.3 COMPETITIVE ASSAYS 101
8.3.1 REDUCED SELECTIVITY AND SENSITIVITY OF COMPETITIVE ASSAYS IN RELATION TO SANDWICH ASSAYS COULD HAMPER MARKET GROWTH 101
TABLE 36 LATERAL FLOW ASSAY COMPONENTS MARKET FOR COMPETITIVE ASSAYS,
BY COUNTRY, 2020–2027 (USD MILLION) 102
8.4 MULTIPLEX DETECTION ASSAYS 102
8.4.1 INCREASING ADOPTION OF MULTI-ANALYTE ASSAYS AMONG CLINICIANS TO DRIVE MARKET GROWTH 102
TABLE 37 LATERAL FLOW ASSAY COMPONENTS MARKET FOR MULTIPLEX DETECTION ASSAYS, BY COUNTRY, 2020–2027 (USD MILLION) 103
9 LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER 104
9.1 INTRODUCTION 105
TABLE 38 LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 105
9.2 MEDICAL DEVICE MANUFACTURING COMPANIES 105
9.2.1 INCREASING USE OF POC TESTS IS DRIVING THE ADOPTION OF LATERAL FLOW ASSAY COMPONENTS AMONG MEDICAL DEVICE MANUFACTURING COMPANIES 105
TABLE 39 LATERAL FLOW ASSAY COMPONENTS MARKET FOR MEDICAL DEVICE MANUFACTURING COMPANIES, BY COUNTRY, 2020–2027 (USD MILLION) 106
9.3 MEDICAL DEVICE CONTRACT MANUFACTURING COMPANIES 106
9.3.1 GROWING INCLINATION TOWARD FAST AND EARLY DIAGNOSIS, ESPECIALLY IN RELATION TO THE CURRENT COVID-19 SCENARIO, WILL DRIVE MARKET GROWTH 106
TABLE 40 LATERAL FLOW ASSAY COMPONENTS MARKET FOR MEDICAL DEVICE CONTRACT MANUFACTURING COMPANIES, BY COUNTRY,
2020–2027 (USD MILLION) 107
 
10 LATERAL FLOW ASSAY COMPONENTS MARKET, BY REGION 108
10.1 INTRODUCTION 109
FIGURE 22 CHINA TO REGISTER THE HIGHEST GROWTH IN THE LATERAL FLOW ASSAY COMPONENTS MARKET DURING THE FORECAST PERIOD 109
TABLE 41 LATERAL FLOW ASSAY COMPONENTS MARKET, BY REGION,
2020–2027 (USD MILLION) 110
10.2 NORTH AMERICA 110
TABLE 42 NORTH AMERICA: MACROECONOMIC INDICATORS 110
FIGURE 23 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET SNAPSHOT 111
TABLE 43 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY COUNTRY, 2020–2027 (USD MILLION) 112
TABLE 44 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE, 2020–2027 (USD MILLION) 112
TABLE 45 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 112
TABLE 46 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY PAD TYPE, 2020–2027 (USD MILLION) 113
TABLE 47 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY APPLICATION, 2020–2027 (USD MILLION) 113
TABLE 48 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 114
TABLE 49 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY TECHNIQUE, 2020–2027 (USD MILLION) 114
TABLE 50 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY END USER, 2020–2027 (USD MILLION) 115
10.2.1 US 115
10.2.1.1 Increasing R&D investments and venture capital funding from both large and small firms towards the development of lateral flow assay diagnostics to drive market growth in the US 115
TABLE 51 US: MACROECONOMIC INDICATORS 116
TABLE 52 US: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 116
TABLE 53 US: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 116
TABLE 54 US: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 117
TABLE 55 US: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION,
2020–2027 (USD MILLION) 117
TABLE 56 US: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 118
TABLE 57 US: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE,
2020–2027 (USD MILLION) 118
TABLE 58 US: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 119
10.2.2 CANADA 119
10.2.2.1 Lateral flow assay components market in Canada is estimated to grow at a relatively lower rate than the US 119
TABLE 59 CANADA: MACROECONOMIC INDICATORS 119
TABLE 60 CANADA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 120
TABLE 61 CANADA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 120
TABLE 62 CANADA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE, 2020–2027 (USD MILLION) 120
TABLE 63 CANADA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 121
TABLE 64 CANADA: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 121
TABLE 65 CANADA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 122
TABLE 66 CANADA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER, 2020–2027 (USD MILLION) 122
10.3 EUROPE 122
TABLE 67 EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 123
TABLE 68 EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 123
TABLE 69 EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 123
TABLE 70 EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE, 2020–2027 (USD MILLION) 124
TABLE 71 EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 124
TABLE 72 EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 125
TABLE 73 EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 125
TABLE 74 EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER, 2020–2027 (USD MILLION) 126
10.3.1 GERMANY 126
10.3.1.1 Growing demand for POC testing to drive the lateral flow assay components market in Germany 126
TABLE 75 GERMANY: MACROECONOMIC INDICATORS 126
TABLE 76 GERMANY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 127
TABLE 77 GERMANY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 127
TABLE 78 GERMANY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE, 2020–2027 (USD MILLION) 127
TABLE 79 GERMANY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 128
TABLE 80 GERMANY: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 128
TABLE 81 GERMANY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 129
TABLE 82 GERMANY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER, 2020–2027 (USD MILLION) 129
10.3.2 FRANCE 129
10.3.2.1 High prevalence of age-related chronic diseases and infectious diseases to drive market growth in France 129
TABLE 83 FRANCE: MACROECONOMIC INDICATORS 130
TABLE 84 FRANCE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 130
TABLE 85 FRANCE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 130
TABLE 86 FRANCE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE, 2020–2027 (USD MILLION) 131
TABLE 87 FRANCE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 131
TABLE 88 FRANCE: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 132
TABLE 89 FRANCE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 132
TABLE 90 FRANCE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER, 2020–2027 (USD MILLION) 133
10.3.3 UK 133
10.3.3.1 Severe impact of the second wave of COVID-19 in the first half of 2021 resulted in higher adoption of rapid COVID tests in the UK 133
TABLE 91 UK: MACROECONOMIC INDICATORS 134
TABLE 92 UK: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 134
TABLE 93 UK: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 134
TABLE 94 UK: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 135
TABLE 95 UK: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION,
2020–2027 (USD MILLION) 135
TABLE 96 UK: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 136
TABLE 97 UK: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE,
2020–2027 (USD MILLION) 136
TABLE 98 UK: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 137
10.3.4 ITALY 137
10.3.4.1 Growing initiatives towards decentralization of medical services in Italy are contributing to the market growth in the country 137
TABLE 99 ITALY: MACROECONOMIC INDICATORS 137
TABLE 100 ITALY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 138
TABLE 101 ITALY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 138
TABLE 102 ITALY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 138
TABLE 103 ITALY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 139
TABLE 104 ITALY: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 139
TABLE 105 ITALY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE,
2020–2027 (USD MILLION) 140
TABLE 106 ITALY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 140
10.3.5 SPAIN 140
10.3.5.1 Increasing focus of international organizations and domestic players on the development of POC products in the country to drive market growth 140
TABLE 107 SPAIN: MACROECONOMIC INDICATORS 141
TABLE 108 SPAIN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 141
TABLE 109 SPAIN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 142
TABLE 110 SPAIN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 142
TABLE 111 SPAIN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 142
TABLE 112 SPAIN: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 143
TABLE 113 SPAIN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 143
TABLE 114 SPAIN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 144
10.3.6 REST OF EUROPE 144
TABLE 115 ROE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 144
TABLE 116 ROE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 145
TABLE 117 ROE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 145
TABLE 118 ROE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 145
TABLE 119 ROE: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 146
TABLE 120 ROE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE,
2020–2027 (USD MILLION) 146
TABLE 121 ROE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 147
10.4 ASIA PACIFIC 147
FIGURE 24 ASIA PACIFIC: LATERAL FLOW ASSAY COMPONENTS MARKET SNAPSHOT 148
TABLE 122 APAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY COUNTRY,
2020–2027 (USD MILLION) 149
TABLE 123 APAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 149
TABLE 124 APAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 149
TABLE 125 APAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 150
TABLE 126 APAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 150
TABLE 127 APAC: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 151
TABLE 128 APAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE,
2020–2027 (USD MILLION) 151
TABLE 129 APAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 152
10.4.1 CHINA 152
10.4.1.1 Higher exports of lateral flow assay components during the COVID-19 pandemic to drive market growth in the country 152
TABLE 130 CHINA: MACROECONOMIC INDICATORS 153
TABLE 131 CHINA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 153
TABLE 132 CHINA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 153
TABLE 133 CHINA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 154
TABLE 134 CHINA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 154
TABLE 135 CHINA: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 155
TABLE 136 CHINA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 155
TABLE 137 CHINA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 156
10.4.2 JAPAN 156
10.4.2.1 Increasing prevalence of age-related illnesses driving the growth of the lateral flow assay components market in Japan 156
TABLE 138 JAPAN: MACROECONOMIC INDICATORS 157
TABLE 139 JAPAN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 157
TABLE 140 JAPAN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 157
TABLE 141 JAPAN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 158
TABLE 142 JAPAN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 158
TABLE 143 JAPAN: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 159
TABLE 144 JAPAN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 159
TABLE 145 JAPAN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 160
10.4.3 INDIA 160
10.4.3.1 Increasing number of local manufacturers, growing healthcare concerns, and rising income levels to propel the growth of this market 160
TABLE 146 INDIA: MACROECONOMIC INDICATORS 160
TABLE 147 INDIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 161
TABLE 148 INDIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 161
TABLE 149 INDIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 161
TABLE 150 INDIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 162
TABLE 151 INDIA: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 162
TABLE 152 INDIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE,
2020–2027 (USD MILLION) 163
TABLE 153 INDIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 163
10.4.4 AUSTRALIA 164
10.4.4.1 Increasing prevalence of infectious diseases, especially influenza, to drive the growth of the lateral flow assay components market in Australia 164
TABLE 154 AUSTRALIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 164
TABLE 155 AUSTRALIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 164
TABLE 156 AUSTRALIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE, 2020–2027 (USD MILLION) 165
TABLE 157 AUSTRALIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 165
TABLE 158 AUSTRALIA: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 166
TABLE 159 AUSTRALIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 166
TABLE 160 AUSTRALIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER, 2020–2027 (USD MILLION) 167
10.4.5 REST OF ASIA PACIFIC 167
TABLE 161 ROAPAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 167
TABLE 162 ROAPAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 168
TABLE 163 ROAPAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE, 2020–2027 (USD MILLION) 168
TABLE 164 ROAPAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 168
TABLE 165 ROAPAC: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 169
TABLE 166 ROAPAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 169
TABLE 167 ROAPAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER, 2020–2027 (USD MILLION) 170
 
10.5 LATIN AMERICA 170
10.5.1 HIGH DEMAND FOR HIV POC DEVICES IN THE REGION TO SUPPORT THE GROWTH OF THE MARKET 170
TABLE 168 LATIN AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE, 2020–2027 (USD MILLION) 171
TABLE 169 LATIN AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 171
TABLE 170 LATIN AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD
TYPE, 2020–2027 (USD MILLION) 171
TABLE 171 LATIN AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY APPLICATION, 2020–2027 (USD MILLION) 172
TABLE 172 LATIN AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 172
TABLE 173 LATIN AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY TECHNIQUE, 2020–2027 (USD MILLION) 173
TABLE 174 LATIN AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY END USER, 2020–2027 (USD MILLION) 173
10.6 MIDDLE EAST & AFRICA 173
10.6.1 SIGNIFICANT SUPPORT FROM GOVERNMENTS AND GLOBAL FIRMS TOWARDS EXPANDING HEALTHCARE SERVICES DRIVES THE ADOPTION OF LATERAL FLOW ASSAYS 173
TABLE 175 MIDDLE EAST & AFRICA: MACROECONOMIC INDICATORS 174
TABLE 176 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY TYPE, 2020–2027 (USD MILLION) 174
TABLE 177 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 175
TABLE 178 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY PAD TYPE, 2020–2027 (USD MILLION) 175
TABLE 179 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY APPLICATION, 2020–2027 (USD MILLION) 175
TABLE 180 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 176
TABLE 181 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY TECHNIQUE, 2020–2027 (USD MILLION) 176
TABLE 182 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY END USER, 2020–2027 (USD MILLION) 177
11 COMPETITIVE LANDSCAPE 178
11.1 OVERVIEW 178
11.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 178
FIGURE 25 OVERVIEW OF STRATEGIES ADOPTED BY MAJOR PLAYERS IN THE LATERAL FLOW ASSAY COMPONENTS MARKET 179
11.3 REVENUE SHARE ANALYSIS FOR KEY PLAYERS IN THE LATERAL FLOW ASSAY COMPONENTS MARKET 179
FIGURE 26 REVENUE SHARE ANALYSIS FOR THE KEY PLAYERS
IN THE LATERAL FLOW ASSAY COMPONENTS MARKET 180
11.4 MARKET SHARE ANALYSIS 180
FIGURE 27 LATERAL FLOW ASSAY COMPONENTS MARKET SHARE ANALYSIS, BY KEY PLAYER (2021) 181
TABLE 183 LATERAL FLOW ASSAY COMPONENTS MARKET: DEGREE OF COMPETITION 182
11.5 R&D ASSESSMENT OF KEY PLAYERS 183
FIGURE 28 R&D EXPENDITURE: MAJOR PLAYERS IN THE LATERAL FLOW ASSAY COMPONENTS MARKET, 2018 VS. 2020 183
11.6 GEOGRAPHIC REVENUE ASSESSMENT OF KEY PLAYERS 183
FIGURE 29 GEOGRAPHIC REVENUE ASSESSMENT: LATERAL FLOW ASSAY COMPONENTS MARKET (2021) 184
11.7 COMPANY EVALUATION QUADRANT 184
11.7.1 STARS 184
11.7.2 PERVASIVE PLAYERS 184
11.7.3 EMERGING LEADERS 185
11.7.4 PARTICIPANTS 185
FIGURE 30 LATERAL FLOW ASSAY COMPONENTS MARKET: COMPANY EVALUATION MATRIX, 2021 185
11.8 COMPETITIVE BENCHMARKING 186
11.8.1 OVERALL COMPANY FOOTPRINT 186
TABLE 184 OVERALL COMPANY FOOTPRINT (17 COMPANIES) 186
TABLE 185 COMPANY FOOTPRINT: BY TYPE (17 COMPANIES) 187
TABLE 186 COMPANY FOOTPRINT: BY REGION (17 COMPANIES) 188
11.9 COMPETITIVE SCENARIO 188
11.9.1 DEALS 189
TABLE 187 DEALS, JANUARY 2019–FEBRUARY 2022 189
11.9.2 OTHER DEVELOPMENTS 189
TABLE 188 OTHER DEVELOPMENTS, JANUARY 2019–FEBRUARY 2022 189
12 COMPANY PROFILES 190
12.1 KEY PLAYERS 190
(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
12.1.1 DANAHER CORPORATION (PALL CORPORATION AND CYTIVA LIFE SCIENCE) 190
TABLE 189 DANAHER CORPORATION: BUSINESS OVERVIEW 190
FIGURE 31 DANAHER CORPORATION: COMPANY SNAPSHOT (2020) 191
12.1.2 SARTORIUS STEDIM BIOTECH 195
TABLE 190 SARTORIUS STEDIM BIOTECH: BUSINESS OVERVIEW 195
12.1.3 MERCK KGAA 199
TABLE 191 MERCK KGAA: BUSINESS OVERVIEW 199
FIGURE 33 MERCK KGAA: COMPANY SNAPSHOT (2020) 200
12.1.4 AHLSTROM-MUNKSJÖ 204
TABLE 192 AHLSTROM-MUNKSJÖ: BUSINESS OVERVIEW 204
FIGURE 34 AHLSTROM-MUNKSJÖ: COMPANY SNAPSHOT (2020) 205
12.1.5 ADVANCED MICRODEVICES PVT. LTD. 208
TABLE 193 ADVANCED MICRODEVICES PVT. LTD.: BUSINESS OVERVIEW 208
12.1.6 DCN DIAGNOSTICS 210
TABLE 194 DCN DIAGNOSTICS: BUSINESS OVERVIEW 210
12.2 OTHER PLAYERS 211
12.2.1 FORTIS LIFE SCIENCES 211
TABLE 195 FORTIS LIFE SCIENCES: BUSINESS OVERVIEW 211
12.2.2 HANGZHOU COBETTER FILTRATION EQUIPMENT CO. LTD 212
TABLE 196 HANGZHOU COBETTER FILTRATION EQUIPMENT CO. LTD.:
BUSINESS OVERVIEW 212
12.2.3 AXIVA SICHEM BIOTECH 214
TABLE 197 AXIVA SICHEM BIOTECH: BUSINESS OVERVIEW 214
12.2.4 NUPORE FILTRATION SYSTEM 216
TABLE 198 NUPORE FILTRATION SYSTEM: BUSINESS OVERVIEW 216
12.2.5 BALLYA BIO 217
TABLE 199 BALLYA BIO: BUSINESS OVERVIEW 217
12.2.6 RUNBIO BIOTECH CO. LTD. 219
TABLE 200 RUNBIO BIOTECH CO. LTD.: BUSINESS OVERVIEW 219
12.2.7 NEENAH GESSNER 220
TABLE 201 NEENAH GESSNER: BUSINESS OVERVIEW 220
12.2.8 MAXIM BIOMEDICAL 221
TABLE 202 MAXIM BIOMEDICAL: BUSINESS OVERVIEW 221
12.2.9 CYTODIAGNOSTICS 222
TABLE 203 CYTODIAGNOSTICS: BUSINESS OVERVIEW 222
12.2.10 SENOVA GMBH 223
TABLE 204 SENOVA GMBH: BUSINESS OVERVIEW 223
*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.
13 APPENDIX 224
13.1 DISCUSSION GUIDE 224
13.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 229
13.3 AVAILABLE CUSTOMIZATIONS 231
13.4 RELATED REPORTS 231
13.5 AUTHOR DETAILS 232

US Healthcare Environmental Services Market by Type (Janitorial/Core-Cleaning, Infection Control & Prevention, Front-of-house cleaning & Brand Experie...

Publisher:        MarketsandMarkets

# of Pages:        126

Rating: 

1 User License $4,950

Publication Date:  March, 2022

Price:       $4,950 / User License




1 INTRODUCTION 15
1.1 OBJECTIVES OF THE STUDY 15
1.2 MARKET DEFINITION & SCOPE 15
1.2.1 INCLUSIONS & EXCLUSIONS OF THE STUDY 16
1.2.2 MARKET SEGMENTATION 16
FIGURE 1 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET SEGMENTATION 16
1.2.3 YEARS CONSIDERED FOR THE STUDY 17
1.3 CURRENCY 17
TABLE 1 EXCHANGE RATES UTILIZED FOR CONVERSION TO USD 17
1.4 STAKEHOLDERS 18
2 RESEARCH METHODOLOGY 19
2.1 RESEARCH APPROACH 19
FIGURE 2 RESEARCH DESIGN 19
2.1.1 SECONDARY RESEARCH 20
2.1.1.1 Key data from secondary sources 21
2.1.2 PRIMARY RESEARCH 21
FIGURE 3 PRIMARY SOURCES 22
2.1.2.1 Key data from primary sources 23
2.1.2.2 Insights from primary experts 23
2.1.2.3 Breakdown of primary interviews 24
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE (SUPPLY & DEMAND SIDE) AND DESIGNATION 24
2.2 MARKET SIZE ESTIMATION 25
FIGURE 5 MARKET SIZE APPROACH – REVENUE SHARE ANALYSIS 25
FIGURE 6 CAGR PROJECTIONS FROM THE ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 26
FIGURE 7 DEMAND-SIDE APPROACH 28
2.3 DATA TRIANGULATION 29
FIGURE 8 DATA TRIANGULATION METHODOLOGY 29
2.4 MARKET RANKING ANALYSIS 30
2.5 ASSUMPTIONS FOR THE STUDY 30
2.6 LIMITATIONS 31
2.6.1 METHODOLOGY-RELATED LIMITATIONS 31
2.6.2 SCOPE-RELATED LIMITATIONS 31
2.7 RISK ASSESSMENT 31
TABLE 2 RISK ASSESSMENT: US HEALTHCARE ENVIRONMENTAL SERVICES MARKET 31
 
3 EXECUTIVE SUMMARY 32
FIGURE 9 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET, BY TYPE,
2021 VS. 2026 (USD MILLION) 32
FIGURE 10 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET,
BY FACILITY TYPE, 2021 VS. 2026 (USD MILLION) 33
4 PREMIUM INSIGHTS 34
4.1 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET OVERVIEW 34
FIGURE 11 STRINGENT REGULATORY GUIDELINES ON INFECTION CONTROL & PREVENTION METHODS IS A KEY FACTOR DRIVING THE MARKET GROWTH 34
4.2 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET, BY TYPE AND FACILITY TYPE 35
FIGURE 12 JANITORIAL/CORE-CLEANING SERVICES ACCOUNTED FOR THE LARGEST SHARE OF THE US HEALTHCARE ENVIRONMENTAL SERVICES
MARKET IN 2020 35
4.3 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET, BY FACILITY TYPE (2021–2026) 36
FIGURE 13 ACUTE CARE FACILITIES TO DOMINATE THE US HEALTHCARE ENVIRONMENTAL SERVICES MARKET DURING THE FORECAST PERIOD 36
5 MARKET OVERVIEW 37
5.1 INTRODUCTION 37
5.2 MARKET DYNAMICS 37
TABLE 3 MARKET DYNAMICS: HEALTHCARE ENVIRONMENTAL SERVICES MARKET 37
5.2.1 MARKET DRIVERS 38
5.2.1.1 Increasing prevalence of Hospital-acquired infections (HAIs) 38
5.2.1.2 Rising number of hospital admissions and surgeries 39
TABLE 4 US: PERCENTAGE INCREASE IN THE NUMBER OF SURGERIES PERFORMED 39
FIGURE 14 TOTAL ADMISSIONS IN ALL US HOSPITALS 40
FIGURE 15 TOTAL NUMBER OF HOSPITALS IN THE US 40
5.2.1.3 Shortage of in-house expertise and the rising need to reduce healthcare costs 41
5.2.1.4 Increasing outsourcing of cleaning services 41
5.2.2 MARKET RESTRAINTS 41
5.2.2.1 Healthcare facilities with an in-house EVS department 41
5.2.3 MARKET OPPORTUNITIES 42
5.2.3.1 Sustained acquisitions among strategic & financial buyers 42
TABLE 5 COMPANY ACQUISITIONS 42
5.2.4 MARKET CHALLENGES 42
5.2.4.1 Noncompliance with cleaning standards by EVS providers 42
5.3 INDUSTRY TRENDS 43
5.3.1 EMERGENCE OF NEW SURFACE DISINFECTANTS &
GREEN CLEANING PRODUCTS 43
5.3.2 DISINFECTION ROBOTS 44
5.3.3 MONITORING TOOLS FOR CLEANING QUALITY ASSESSMENT 44
5.4 TECHNOLOGY ANALYSIS 45
TABLE 6 TECHNOLOGY INNOVATION IN THE HEALTHCARE ENVIRONMENTAL
SERVICES MARKET 45
5.5 PATENT ANALYSIS 45
5.5.1 PATENT PUBLICATION TRENDS FOR HEALTHCARE ENVIRONMENTAL SERVICES 46
FIGURE 16 PATENT PUBLICATION TRENDS (JANUARY 2011–DECEMBER 2021) 46
5.5.2 JURISDICTION AND TOP APPLICANT ANALYSIS 47
FIGURE 17 TOP APPLICANTS & OWNERS (COMPANIES/INSTITUTIONS) FOR HEALTHCARE ENVIRONMENTAL SERVICES PATENTS (JANUARY 2011–JANUARY 2022) 47
FIGURE 18 TOP APPLICANT COUNTRIES/REGIONS FOR HEALTHCARE ENVIRONMENTAL SERVICES PATENTS (JANUARY 2011–JANUARY 2022) 48
TABLE 7 LIST OF PATENTS/PATENT APPLICATIONS IN THE HEALTHCARE ENVIRONMENTAL SERVICES MARKET, 2020–2021 48
5.6 IMPACT OF COVID-19 ON THE HEALTHCARE ENVIRONMENTAL SERVICES MARKET 50
6 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET, BY TYPE 51
6.1 INTRODUCTION 52
TABLE 8 US: HEALTHCARE ENVIRONMENTAL SERVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 52
6.2 JANITORIAL SERVICES/CORE-CLEANING SERVICES 52
6.2.1 MANDATORY REGULAR CLEANING AND DISINFECTION OF HEALTHCARE FACILITIES TO DRIVE THE MARKET GROWTH 52
6.3 INFECTION PREVENTION & CONTROL SERVICES 53
TABLE 9 US: INFECTION PREVENTION & CONTROL SERVICE MARKET, BY TYPE,
2019–2026 (USD MILLION) 53
6.3.1 SPECIALIZED CLEANING SERVICES 53
6.3.1.1 Rising adoption of specialized services to reduce HAIs to drive the market growth 53
6.3.2 INFECTION PREVENTION & CONTROL CONSULTATION SERVICES 53
6.3.2.1 The provision of customized environmental services specific
to a healthcare facility ensures market demand 53
6.4 ENHANCED CLEANING TECHNOLOGY 54
6.4.1 RISING DEMAND FOR ADVANCED CLEANING SOLUTIONS TO DRIVE THE SEGMENT GROWTH 54
TABLE 10 EXAMPLES OF COMPANIES PROVIDING TECHNOLOGY & INNOVATION IN HEALTHCARE EVS 54
6.5 FRONT-OF-HOUSE CLEANING AND BRAND EXPERIENCE 56
6.5.1 RISING AWARENESS TOWARDS A CLEAN AND SAFE ENVIRONMENT DURING PANDEMICS TO SUSTAIN THE MARKET GROWTH 56
6.6 OTHER SERVICES 56
 
7 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET, BY FACILITY TYPE 57
7.1 INTRODUCTION 58
FIGURE 19 STATES WITH THE HIGHEST NUMBER OF COVID-19 ADMISSIONS
(FEBRUARY 2022) 58
TABLE 11 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET, BY FACILITY TYPE, 2019–2026 (USD MILLION) 59
7.2 ACUTE-CARE FACILITIES 59
TABLE 12 US: HEALTHCARE ENVIRONMENTAL SERVICES FOR ACUTE-CARE SETTINGS, BY TYPE 2019–2026 (USD MILLION) 59
7.2.1 ACUTE HOSPITALS 60
7.2.1.1 Increasing hospital admissions due to COVID-19 and the rising prevalence of HAIs propel the market growth 60
FIGURE 20 NUMBER OF HAIS REPORTED BY GENERAL ACUTE CARE HOSPITALS
IN THE US (2020) 60
FIGURE 21 HAIS REPORTED BY GENERAL ACUTE CARE HOSPITALS IN THE US (2020) 61
FIGURE 22 HAIS REPORTED BY CRITICAL ACCESS HOSPITALS (CAHS) IN THE US (2018) 61
7.2.2 MILITARY TREATMENT FACILITY 61
7.2.2.1 The increasing number of military ambulatory health services & funding to drive the market growth 61
FIGURE 23 MILITARY HEALTH SYSTEMS FACILITIES IN THE US (2021) 62
7.2.3 CHILDREN’S HOSPITALS 62
7.2.3.1 Rising cases of COVID-19 and infection-related mortality rates among children drive the market growth 62
7.2.4 AMBULATORY SURGERY CENTERS (ASCS) 63
7.2.4.1 ASCs save time and reduce the risk of HAIS; key factor driving the market growth 63
FIGURE 24 US SURGERY CASES BY SETTING: ASC VS. HOPD (2005-2020) 64
7.2.5 ACADEMIC MEDICAL CENTERS (AMCS) 64
7.2.5.1 Healthcare capacity expansion during COVID-19 drives the adoption of healthcare environmental services in AMCs 64
7.3 POST-ACUTE CARE FACILITIES 64
TABLE 13 US: HEALTHCARE ENVIRONMENTAL SERVICES FOR POST-ACUTE CARE SETTINGS, BY TYPE 2019–2026 (USD MILLION) 65
7.3.1 LONG-TERM ACUTE HOSPITALS (LTACH) 65
7.3.1.1 Increasing risk of infection due to prolonged hospital stays to drive the market growth 65
7.3.2 SKILLED NURSING FACILITIES (SNF) 66
7.3.2.1 Increasing admissions of elderly people in skilled nursing facilities to drive the market growth 66
7.3.3 OTHER POST-ACUTE CARE FACILITIES 66
7.4 NON-ACUTE CARE FACILITIES 67
TABLE 14 US: ENVIRONMENTAL SERVICES MARKET FOR NON-ACUTE CARE SETTINGS, BY TYPE, 2019–2026 (USD MILLION) 67
7.4.1 PHYSICIAN’S OFFICES AND CLINICS 67
7.4.1.1 High patient traffic leads to continuous cleaning & maintenance to drive the market growth 67
7.4.2 OTHER NON-ACUTE CARE FACILITIES 68
FIGURE 25 DISTRIBUTION OF INDUSTRY MEDICAL AND HEALTH R&D INVESTMENTS,
BY SEGMENT (2020) 68
8 COMPETITIVE LANDSCAPE 70
8.1 OVERVIEW 70
8.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 70
8.2.1 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN THE HEALTHCARE ENVIRONMENTAL SERVICES MARKET 71
8.3 REVENUE SHARE ANALYSIS OF THE TOP MARKET PLAYERS 72
8.4 MARKET RANKING ANALYSIS 73
FIGURE 27 US HEALTHCARE ENVIRONMENTAL SERVICE MARKET RANKING,
BY KEY PLAYER, 2020 73
8.5 COMPETITIVE BENCHMARKING 75
TABLE 15 FOOTPRINT OF COMPANIES IN THE HEALTHCARE ENVIRONMENTAL
SERVICES MARKET 75
TABLE 16 SERVICE FOOTPRINT OF COMPANIES 76
TABLE 17 END-USER FOOTPRINT OF COMPANIES 77
8.6 COMPETITIVE LEADERSHIP MAPPING 77
8.6.1 STARS 78
8.6.2 EMERGING LEADERS 78
8.6.3 PERVASIVE PLAYERS 78
8.6.4 PARTICIPANTS 78
FIGURE 28 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET:
COMPETITIVE LEADERSHIP MAPPING (2021) 79
8.7 COMPETITIVE SCENARIO 80
8.7.1 SERVICE APPROVALS/ENHANCEMENTS 80
8.7.2 DEALS 81
TABLE 19 DEALS, 2018–2022 81
8.7.3 OTHER DEVELOPMENTS 82
9 COMPANY PROFILES 83
(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
9.1 SODEXO GLOBAL 83
TABLE 21 SODEXO GLOBAL: BUSINESS OVERVIEW 83
FIGURE 29 SODEXO GLOBAL: COMPANY SNAPSHOT (2021) 84
9.2 COMPASS GROUP (CROTHALL HEALTHCARE (US)) 87
TABLE 22 COMPASS GROUP: BUSINESS OVERVIEW 87
FIGURE 30 COMPASS GROUP: COMPANY SNAPSHOT (2021) 88
 
9.3 ARAMARK CORPORATION 90
TABLE 23 ARAMARK CORPORATION: BUSINESS OVERVIEW 90
FIGURE 31 ARAMARK CORPORATION: COMPANY SNAPSHOT (2021) 91
9.4 HOSPITAL HOUSEKEEPING SYSTEMS (HHS) (US) 94
TABLE 24 HOSPITAL HOUSEKEEPING SYSTEMS (HHS): BUSINESS OVERVIEW 94
9.5 HEALTHCARE SERVICES GROUP, INC. 97
TABLE 25 HEALTHCARE SERVICES GROUP, INC.: BUSINESS OVERVIEW 97
FIGURE 32 HEALTHCARE SERVICES GROUP: COMPANY SNAPSHOT (2020) 98
9.6 ABM INDUSTRIES INCORPORATED 100
TABLE 26 ABM INDUSTRIES INCORPORATED: BUSINESS OVERVIEW 100
FIGURE 33 ABM INDUSTRIES INCORPORATED: COMPANY SNAPSHOT (2020) 101
9.7 OCTOCLEAN 103
TABLE 27 OCTOCLEAN: BUSINESS OVERVIEW 103
9.8 SERVICEMASTER CLEAN (SERVICEMASTER TBS) 105
TABLE 28 SERVICEMASTER CLEAN.: BUSINESS OVERVIEW 105
9.9 CORVUS JANITORIAL SYSTEMS 107
TABLE 29 CORVUS JANITORIAL SYSTEMS: BUSINESS OVERVIEW 107
9.10 BRAVO! BUILDING SERVICES 109
TABLE 30 BRAVO! BUILDING SERVICES: BUSINESS OVERVIEW 109
9.11 POWERLINK ENVIRONMENTAL SERVICES, LLC 111
TABLE 31 POWERLINK ENVIRONMENTAL SERVICES, LLC: BUSINESS OVERVIEW 111
9.12 JANI-KING INTERNATIONAL, INC. 112
TABLE 32 JANI- KING INTERNATIONAL, INC: BUSINESS OVERVIEW 112
9.13 AVI FOOD SYSTEMS(US) 114
TABLE 33 AVI FOOD SYTEMS, INC.: BUSINESS OVERVIEW 114
9.14 SERVICON 115
TABLE 34 SERVICON: BUSINESS OVERVIEW 115
9.15 XANITOS, INC. 117
TABLE 35 XANITOS, INC.: BUSINESS OVERVIEW 117
9.16 STATHAKIS 119
TABLE 36 STATHAKIS: BUSINESS OVERVIEW 119
*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.
10 APPENDIX 120
10.1 INSIGHTS FROM INDUSTRY EXPERTS 120
10.2 DISCUSSION GUIDE 121
10.3 KNOWLEDGESTORE: MARKETSANDMARKETS SUBSCRIPTION PORTAL 124
10.4 AVAILABLE CUSTOMIZATIONS 126
10.5 RELATED REPORTS 126
10.6 AUTHOR DETAILS 127